Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis

Published:2024-03-12 Issue:5 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Chard Declan T.¹^ORCID

Affiliation:

1. From the NMR Research Unit (D.T.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London; and National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (D.T.C.), United Kingdom.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000209246

Reference10 articles.

1. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

2. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

3. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque

4. Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression

5. Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP